News
Global shares fell Monday and U.S. futures and the U.S. dollar also weakened after Moody’s Ratings downgraded the sovereign ...
Biotechnology company Regeneron Pharmaceuticals is buying 23andMe for US$256 million, two months after the genetic testing ...
The May long weekend marks the unofficial start of cottage season for many Canadians, but a new report says some looking to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback